` 0R2B (Danaher Corp) vs S&P 500 Comparison - Alpha Spread

0R2B
vs
S&P 500

Over the past 12 months, 0R2B has underperformed S&P 500, delivering a return of -1% compared to the S&P 500's +26% growth.

Stocks Performance
0R2B vs S&P 500

Loading
0R2B
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
0R2B vs S&P 500

Loading
0R2B
S&P 500
Difference
www.alphaspread.com

Performance By Year
0R2B vs S&P 500

Loading
0R2B
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Danaher Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Danaher Corp
Glance View

Once upon a time, back in 1984, two brothers, Steven and Mitchell Rales, envisioned a company that would revolutionize the manufacturing sphere, setting the roots for what would become Danaher Corporation. Born from the acquisition of a real estate investment trust, they pivoted to a broader industrial manufacturing approach, aligning themselves with the then unique concept of lean manufacturing and continuous improvement – known as the Danaher Business System (DBS). This philosophy helped them transform Danaher into an assembly of high-performance companies. Over the decades, the corporation honed its focus, shedding non-core assets, and refining its portfolio to center on biotechnology, life sciences, environmental and applied solutions, and diagnostics. Through strategic acquisitions and relentless innovation, Danaher has continued to evolve, constantly reshaping itself to meet the demands of critical sectors. Today, Danaher's operations are driven by three powerful segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Its Life Sciences segment enables breakthrough discoveries that advance scientific research, healthcare, and more. Meanwhile, the Diagnostics division delivers critical tools that aid clinical laboratories and physicians in patient care, offering blood and infection analysis technologies, among others. Finally, Environmental & Applied Solutions focuses on water quality and product-identification services, crucial for maintaining health and safety standards across industries. By continually investing in innovation and focusing on operational efficiencies through DBS, Danaher not only positions itself as a leader in these sectors—it harnesses market needs into profitable solutions, ensuring its growth and stability in a competitive global market.

0R2B Intrinsic Value
201.58 USD
Undervaluation 6%
Intrinsic Value
Price $190.15
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett